observed both an increasing trend of glucose intolerance by tumour stage and worse survival among patients with metastatic cancer. 5 However, this study was conducted only in patients with pancreatic cancer, which may account for the differences from our study, as most late‐stage pancreatic cancers will result in glucose intolerance. 22 Diabetes risk may also disproportionately impact certain population groups.
← all excerpts
New-onset prediabetes/diabetes worsens overall survival in patients with cancer: A real-world retrospective cohort study.
1
—
—